Vanda Pharmaceuticals Inc. - 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report covers events occurring on June 16, 2011, specifically the results of the Company's 2011 Annual Meeting of Stockholders and subsequent Board of Directors actions. The filing does not contain financial performance data for a specific reporting period.
Key Financial Metrics
The filing text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes.
Material Changes and Voting Results
At the Annual Meeting, approximately 89.2% of the 28,103,441 shares entitled to vote were represented. The following proposals were approved:
- Proposal 1 (Election of Directors): Richard W. Dugan and Vincent J. Milano were elected as Class II directors for a three-year term.
- Proposal 2 (Auditor Ratification): Stockholders ratified the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2011.
- Proposal 3 (Executive Compensation): Stockholders approved, on an advisory non-binding basis, the compensation of named executive officers.
- Proposal 4 (Compensation Vote Frequency): Stockholders approved holding an advisory vote on executive compensation on an annual basis (1 Year).
Management Commentary and Other Events
Following the Annual Meeting, the Board of Directors made the following committee appointments on June 16, 2011:
- Compensation Committee: Vincent J. Milano was appointed as a member. The committee now consists of Argeris N. Karabelas, Ph.D., H. Thomas Watkins, Howard Pien, and Vincent J. Milano.
- Nominating/Corporate Governance Committee: Steven K. Galson, M.D., was appointed as a member. The committee now consists of Richard W. Dugan, Argeris N. Karabelas, Ph.D., H. Thomas Watkins, and Steven K. Galson, M.D.
Investor Verification Checklist
- Verify the definitive proxy statement (Schedule 14A) filed on April 29, 2011, for detailed background on the executive compensation and director nominees.
- Confirm the effective dates of the new committee memberships for governance compliance.
- Note that the auditor ratification applies specifically to the fiscal year ending December 31, 2011.